Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |